Exchange: NASDAQ·Updated 11:45 AM EDT
ANIP logo

ANIP ANI Pharmaceuticals Inc

$74.25
$0.18
(0.24%)
Today
EarningsNov 6
Mkt Cap$1.71B
Vol51,215.00

About ANIP

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
59

Bullish Sentiment

How do you feel about ANIP?

Dy2ski
$ANIP Actually, a decent job by the CEO and even CFO Carey at yesterday's conference. But pretty clear an acquisition is all that they're thinking about, though which will most likely be dilutive as heck to common shareholders and is probably why the share price is and has been absolute garbage and just hit a 52 week low.
2

Advertisement|Remove ads.